Published Work

Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C

Concerns about reinfection may be limiting HCV treatment uptake among people who use drugs (PWUD), with rates of 17.1/100 person-years in...

Preliminary results from a novel model of HCV care in OST clinics: find 50

Presented at the Western Canada Addiction Forum, May 3-5, Kelowna, Canada, 2019.

Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject

Vancouver’s Downtown Eastside (DTES) faces the interrelated challenges of poverty, homelessness, mental health, addiction, and medical issue

Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject

Many clinicians and insurance providers are reluctant to embrace recent guidelines identifying people who inject drugs (PWID) as a priority

COVID-19 & Sports